Emerging treatments for progressive myoclonus epilepsies
- 17 March 2020
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 20 (4) , 341-350
Abstract
Introduction: Progressive myoclonus epilepsies (PMEs) are a group of neurodegenerative diseases, invariably leading to severe disability or fatal outcome in a few years or decades. Nowadays, PMEs treatment remains challenging with a significant burden of disability for patients. Pharmacotherapy is primarily used to treat seizures, which impact patients’ quality of life. However, new approaches have emerged in the last few years, which try to curb the neurological deterioration of PMEs through a better knowledge of the pathogenetic process. This is a review on the newest therapeutic options for treatment of PMEs. Areas covered: Experimental and clinical results on novel therapeutic approaches for the different forms of PME are reviewed and discussed. Special attention is primarily focused on the efficacy and tolerability outcomes, trying to infer the role novel approaches may have in the future. Expert opinion: The large heterogeneity of disease-causing mechanisms prevents researchers from identifying a single approach to treat PMEs. Understanding of pathophysiologic processes is leading the way to targeted therapies, which, through enzyme replacement or underlying gene defect correction have already proved to potentially strike on neurodegeneration.Keywords
This publication has 84 references indexed in Scilit:
- Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosisJournal of neurosurgery. Pediatrics, 2013
- Vagus nerve stimulation for epilepsy: A review of central mechanismsSurgical Neurology International, 2012
- The role of inflammation in epilepsyNature Reviews Neurology, 2010
- Mitochondrial tRNA mutations and diseaseWIREs RNA, 2010
- Transcranial Magnetic Stimulation for Drug-Resistant Epilepsies: Rationale and Clinical ExperienceEuropean Neurology, 2010
- Gene therapy in epilepsyEpilepsia, 2009
- Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effectsNeuroscience & Biobehavioral Reviews, 2005
- Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?Neuropharmacology, 2003
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Benzodiazepines in the Treatment of Children with EpilepsyEpilepsia, 1986